Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects.
作者信息
Balasse E O, Couturier E, Kornitzer M, Degre S
出版信息
Postgrad Med J. 1975;51 Suppl 1:157.
PMID:768958
Abstract
摘要
相似文献
1
2
A clinical trial of a new fenfluramine preparation (Ponderax PA).一种新型芬氟拉明制剂（Ponderax PA）的临床试验。
Postgrad Med J. 1975;51 Suppl 1:159-60.
3
[Clinical trial of a new long-acting fenfluramine in the treatment of obesity].一种新型长效芬氟拉明治疗肥胖症的临床试验
G Clin Med. 1978 Nov;59(11):486-510.
4
Acceptability of prolonged release fenfluramine capsules in obese patients in general practice.肥胖患者在全科医疗中使用长效氟苯丙胺胶囊的可接受性。
Postgrad Med J. 1975;51 Suppl 1:176-7.
5
A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.氟苯丙胺片（英国药典）与长效胶囊的疗效及可接受性比较。
Postgrad Med J. 1975;51 Suppl 1:160-2.
6
Prolonged action fenfluramine capsules versus fenfluramine tablets in general practice.普通实践中长效芬氟拉明胶囊与芬氟拉明片的比较
Br J Clin Pract. 1975 Jan;29(1):12-13.
7
Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.长效芬氟拉明用于治疗难治性肥胖的非糖尿病患者。
Postgrad Med J. 1975;51 Suppl 1:155-7.
8
Prolonged action fenfluramine in general practice.普通医疗实践中的长效芬氟拉明。
Br J Clin Pract. 1975 Jan;29(1):13-14.
9
A double-blind clinical trial of fenfluramine in the treatment of obesity.
Br J Clin Pract. 1973 Apr;27(4):136-8.
10
Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.芬氟拉明新制剂用于肥胖糖尿病非洲人治疗的评估
Postgrad Med J. 1975;51 Suppl 1:138-9.
引用本文的文献
1
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.芬氟拉明：对其药理特性及在肥胖症治疗中的疗效综述。
Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001.
Zotero 插件